Sio Gene Therapies Inc
(SIOX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2017 | 03-2016 | 03-2015 | 03-2007 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 212,573 | 276,251 | N/A | N/A |
| Receivables | 658 | 970 | N/A | N/A |
| Other current assets | 0 | 0 | 1,104 | 0 |
| TOTAL | $219,688 | $282,086 | $1,108 | $N/A |
| Non-Current Assets | ||||
| PPE Net | 142 | 89 | 9 | N/A |
| Other Non-Current Assets | 2,709 | 323 | 0 | 0 |
| TOTAL | $2,851 | $412 | $9 | $N/A |
| Total Assets | $222,539 | $282,498 | $1,117 | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 8,551 | 622 | 403 | 0 |
| Accrued Expenses | 34,796 | 8,319 | 1,158 | N/A |
| Other current liabilities | 2,919 | 6,814 | 2,307 | N/A |
| TOTAL | $46,266 | $15,755 | $3,868 | $N/A |
| Non-Current Liabilities | ||||
| Long Term Debt | 51,436 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 0 | 0 | 5,000 | 0 |
| TOTAL | $51,436 | $N/A | $5,000 | $N/A |
| Total Liabilities | $97,702 | $15,755 | $8,868 | $N/A |
| Shareholders' Equity | ||||
| Common Shares | 1 | 1 | 0 | N/A |
| Retained earnings | -335,143 | -154,192 | -21,047 | N/A |
| Other shareholders' equity | 378 | 0 | 0 | 0 |
| TOTAL | $124,837 | $266,743 | $-7,751 | $N/A |
| Total Liabilities And Equity | $222,539 | $282,498 | $1,117 | $0 |